CMS Launches Medicare Advantage Qualifying Payment Arrangement Incentive Demonstration
The Centers for Medicare and Medicaid Services is launching the Medicare Advantage Qualifying Payment Arrangement Incentive demonstration.
Cinryze Approved for Preventing Pediatric Angioedema Attacks
The U.S. Food and Drug Administration (FDA) has approved Shire’s Cinryze (C1 esterase inhibitor [human]) to prevent angioedema attacks in children 6 years and older with hereditary angioedema.
Second JAK Inhibitor Drug for RA Approved by FDA
The U.S. Food and Drug Administration (FDA) has approved Incyte Corp.’s Olumiant (baricitinib) 2 mg once-daily oral medication to treat adults with moderately to severe active rheumatoid arthritis.
FDA Approves Marijuana-Based Drug for Seizures
The U.S. Food and Drug Administration has approved the first prescription drug made from marijuana.
FDA Approves Diagnostic Test for Lupus and ANCA-Associated Vasculitis
The U.S. Food and Drug Administration has approved new automated diagnostic tests for lupus and ANCA-associated vasculitis.
Rituxan Approved to Treat Severe Pemphigus Vulgaris
The U.S. Food and Drug Administration has approved Genentech’s Rituxan (rituximab) to treat moderate-tosevere phemphigus vulgaris.
FDA Approves Fast-Acting, Single-Dose Flu Medication
The U.S. Food and Drug Administration (FDA) has approved a new, single-dose medication to treat people 12 years and older who have had the flu for no more than 48 hours.
First EpiPen Generics Get FDA Approval
FDA has approved the first generic versions of Mylan’s EpiPen and EpiPen Jr.
Study Shows Newborns’ Immune Systems Ramp Up After Birth
A new study shows newborns’ immune systems ramp up immediately after birth.
FDA Approves HPV Vaccine for 27- to 45-Year-Old Men and Women
Merck’s Gardasil 9 human papillomavirus (HPV) vaccine has been approved by the U.S. Food and Drug Administration (FDA) for an expanded indication for men and women between the ages of 27 years and 45 years.
